The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage for it to become widely available.

The number of candles on a birthday cake marks time, but it does not tell the full story of aging. Two people born in the same year can look and feel very different decades later.

The FDA cleared the first blood-based in vitro diagnostic test for Alzheimer's disease, the agency announced Friday. The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can ...

What if a blood test could predict potential health problems rather than diagnose when the damage has been done? This is the ...

A new kind of blood test promises to find cancer early—sometimes even before symptoms appear. The pitch is compelling: a single sample of blood could scan the body for dozens of different cancers at ...

Small loops of genetic material may be strong indicators of imminent Alzheimer's disease (AD) symptoms. In a new study ...

When something goes wrong in the brain of people with dementia, often it’s more than one thing. But it can be hard to tease apart multiple brain diseases, especially in the early stages, or even ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

For people with a certain sleep disorder, a simple blood test could help predict the development of dementia years before symptoms appear, a new study indicates. Idiopathic REM sleep behavior disorder ...

GRAIL IS AN American biotech company with an ambitious goal: to develop a blood test for the early detection of over 50 types of cancer. It will not be easy. On February 19th the company announced ...